Resection of Biliary Cystadenoma in a Pregnant Woman: A Case Report With Five Years of Follow-Up
Patryk Patrzałek, Agnieszka Hałoń, Maciej Guziński, Michał Pomorski, Wojciech Tokarczyk, Dariusz Patrzałek

TL;DR
A pregnant woman successfully underwent surgery to remove a rare liver tumor, with no recurrence after five years.
Contribution
This case report highlights successful resection of BCA during pregnancy with long-term follow-up.
Findings
Complete resection of a mucinous hepatobiliary cystadenoma was achieved in a pregnant patient.
Five-year follow-up confirmed no tumor recurrence.
Surgical intervention is recommended for BCAs to prevent potential malignancy.
Abstract
Biliary cystadenomas (BCAs), rare cystic tumors occurring in the biliary system, account for fewer than 5% of cystic lesions in the liver. This case details successful resection in a 29-year-old pregnant woman at seven weeks gestation. Urgent left hemihepatectomy and cholecystectomy removed a mucinous hepatobiliary cystadenoma. Postoperatively, a healthy newborn was delivered by cesarean section. Five-year follow-up showed no recurrence. BCAs present diagnostic challenges due to nonspecific symptoms, and surgical intervention, preferably complete resection, is recommended for potential malignancy, after weighing benefits against complications in critical hepatic vessel lesions.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenetic and Kidney Cyst Diseases · Pediatric Hepatobiliary Diseases and Treatments · Renal and related cancers
